Abstract
Schistosomiasis is a neglected disease for which only one drug is available to the treatment, the praziquantel. Previous experience with other infectious diseases has shown that relying upon only one drug is a dangerous approach, even more, when it is frequently employed as prophylactics, as in the case of praziquantel. Consequently, the need for new pharmacological alternatives to treat …